{"key":"op_491_TH","page":{"url":"https://it.bookimed.com/clinics/country=thailand/procedure=keytruda/","procedure":{"id":491,"slug":"keytruda","name":"Immunoterapia con Keytruda (Pembrolizumab)","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"oncology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":45,"iso":"TH","name":"Thailandia"},"currency":"USD","data_date":"2026-11-15"},"pages":{"clinics_url":"https://it.bookimed.com/clinics/country=thailand/procedure=keytruda/","cost_url":"https://it.bookimed.com/clinics/country=thailand/procedure=keytruda/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":3600,"to":4600,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":13500,"to":22000},"uk":{"from":7000,"to":10500},"by_technique":{"status":"missing","reason":"not_collected"},"by_city":[{"city":"Phuket","from":3800},{"city":"Chiang Mai","from":3600},{"city":"Bangkok","from":3600},{"city":"Pattaya","from":3600}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":4500,"to":8000},{"country_iso":"FR","from":4200,"to":7000},{"country_iso":"GB","from":7000,"to":10500},{"country_iso":"US","from":13500,"to":22000},{"country_iso":"IL","from":4800,"to":6800},{"country_iso":"TR","from":2800,"to":7000},{"country_iso":"MX","from":3800,"to":5500},{"country_iso":"DE","from":6000,"to":8100},{"country_iso":"CA","from":6800,"to":9800},{"country_iso":"AE","from":5600,"to":8600},{"country_iso":"PL","from":4300,"to":5800},{"country_iso":"KR","from":4800,"to":7500},{"country_iso":"CZ","from":3600,"to":5300},{"country_iso":"AT","from":5800,"to":8400},{"country_iso":"ES","from":13600,"to":{"status":"missing","reason":"not_collected"}},{"country_iso":"IT","from":4300,"to":6700},{"country_iso":"CN","from":4500,"to":7200},{"country_iso":"AU","from":4800,"to":7400},{"country_iso":"IN","from":2500,"to":5200},{"country_iso":"MY","from":3800,"to":5400},{"country_iso":"VN","from":4300,"to":6200},{"country_iso":"BR","from":4500,"to":7000},{"country_iso":"EG","from":1500,"to":6300}],"base_country":"US","base_is_fallback":false},"savings":{"pct":73,"variant":">=15%"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":1,"items":[{"id":250,"name":"Bumrungrad International Hospital","city":"Bangkok","rating":4.6,"reviews_count":131,"accreditations":["International Organization for Standardization","Joint Commission International","Global Healthcare Accreditation Program","World's Best Hospitals 2020 by Newsweek","World's Best Hospitals 2021 by Newsweek","World's Best Smart Hospitals 2021 by Newsweek","World's Best Hospitals 2022 by Newsweek","World's Best Smart Hospitals 2023 by Newsweek"],"rank":1,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":{"status":"missing","reason":"not_collected"},"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":362,"slug":"phuket","name":"Phuket","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":3800,"profile":{"city_type":"Island city, capital of Phuket province","access":["Phuket Airport (HKT), 32 km from the city center"],"sources":["https://en.wikipedia.org/wiki/Phuket_City","https://en.wikipedia.org/wiki/Phuket_International_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":420,"slug":"chiang-mai","name":"Chiang Mai","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":3600,"profile":{"city_type":"Largest city in northern Thailand","access":["Chiang Mai Airport (CNX), 4 km from the city center"],"sources":["https://en.wikipedia.org/wiki/Chiang_Mai","https://www.worldtravelguide.net/guides/asia/thailand/chiang-mai/chiang-mai-international-airport/"],"checked_at":"2026-11-03","status":"ok"}},{"id":75,"slug":"bangkok","name":"Bangkok","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":3600,"profile":{"city_type":"Capital and largest city of Thailand","access":["Suvarnabhumi Airport (BKK), 25 km from downtown Bangkok","Don Mueang Airport (DMK), 23 km from the Grand Palace"],"sources":["https://en.wikipedia.org/wiki/Bangkok","https://en.wikipedia.org/wiki/Suvarnabhumi_Airport","https://www.worldtravelguide.net/guides/asia/thailand/bangkok/bangkok-don-mueang-international-airport/"],"checked_at":"2026-11-03","status":"ok"}},{"id":367,"slug":"pattaya","name":"Pattaya","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":3600,"profile":{"city_type":"City in Eastern Thailand, Chonburi province","access":["U-Tapao Airport (UTP), 50 km from Pattaya's Walking Street","Suvarnabhumi Airport (BKK), 120 km from Pattaya by road"],"sources":["https://en.wikipedia.org/wiki/Pattaya","https://en.wikipedia.org/wiki/U-Tapao_International_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Advanced or metastatic melanoma; adjuvant melanoma after resection","Non-small cell lung cancer (alone or with chemotherapy)","Head and neck squamous cell carcinoma","Classical Hodgkin lymphoma (relapsed/refractory)","Urothelial carcinoma","MSI-high/dMMR solid tumors including colorectal cancer","Other approved cancers (cervical, endometrial, gastric, renal, breast)","Merkel cell carcinoma"],"contraindications":["Prior severe hypersensitivity to pembrolizumab or its components","Pregnancy (can harm the fetus)","Severe active autoimmune disease needing immunosuppression (relative)","Active uncontrolled infection (relative; treat first)","Prior solid organ transplant (relative; graft rejection risk)"],"operation_hours":{"min":0.5,"max":1,"unit":"hours","qualifier":"Dose (200 mg every 3 weeks or 400 mg every 6 weeks) infused over 30 minutes, plus brief observation."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":1,"max":35,"unit":"visits","qualifier":"Infusions every 3 or 6 weeks for up to about 2 years (35 three-weekly cycles) or until progression."},"stages":[{"code":"infusion_cycles","label":"Repeated intravenous pembrolizumab infusions every 3 or 6 weeks","after":{"min":0,"max":730,"unit":"days","qualifier":"Spans the whole course from the first infusion."}}],"qualifier":"Number of cycles depends on cancer type, regimen, response and tolerance."},"hospital_nights":{"value":{"min":0,"max":0,"unit":"nights","qualifier":"Per infusion; given as an outpatient infusion with no overnight stay."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"min":0,"max":2,"unit":"days","qualifier":"Outpatient infusion with no surgical recovery; usual activities resume within 0-2 days, depending on fatigue and side effects."},"fly_home_after_days":{"min":1,"max":2,"unit":"days","qualifier":"Outpatient infusion with no wound; flying is possible once no reaction occurs and you feel well."},"back_to_work_days":{"min":0,"max":2,"unit":"days","qualifier":"Most return to usual activities within 0-2 days, depending on fatigue, side effects and cancer type."},"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"No procedural restriction; light activity encouraged. Strenuous exercise within about a week, limited by fatigue."},"final_result_months":{"min":3,"max":6,"unit":"months","qualifier":"Best response often seen within 3-6 months; responses may deepen later."},"result_longevity":"In responders, benefit is often durable, lasting years and sometimes continuing after the course (up to about 2 years) ends. Duration depends on cancer type, stage and biomarkers.","main_risks":["Immune-related organ inflammation (lungs, colon, liver, thyroid, kidneys, skin)","Fatigue, rash, itching, diarrhea, nausea","Infusion-related reactions","Type 1 diabetes, adrenal or pituitary insufficiency","Myocarditis (rare)","Serious or fatal immune events needing steroids and interruption"],"complication_rate_pct":{"min":10,"max":20,"unit":"percent","qualifier":"Grade 3-5 treatment-related adverse events with monotherapy in pivotal trials; higher with chemotherapy or TKIs."},"revision_rate_pct":{"status":"missing","reason":"not_collected"},"success":{"metric":"Overall survival at 5 years (advanced NSCLC, PD-L1 ≥50%)","value":31.9,"horizon":"5 years","source":{"status":"missing","reason":"not_collected"},"evidence_status":"limited"},"scars":"No scarring is expected; at most there is a tiny, temporary mark at the IV cannulation site.","pain":"Minimal; only mild discomfort from IV cannulation. Side effects such as joint or muscle pain may occur in some patients.","preparation":["Confirmed cancer and approved indication; biomarker testing if relevant","Baseline blood tests: liver, kidney, thyroid, glucose","Baseline imaging for staging","Review of autoimmune history, transplant history and current medications","Pregnancy test and contraception counseling where relevant","Discussion of side effects and when to report symptoms urgently","Hepatitis B/C and HIV screening; exclude active tuberculosis","Baseline ECOG performance status assessment","Adequate venous access for intravenous infusion"],"recovery_timeline":[{"phase":"Infusion day","description":"About 30-minute IV infusion with brief observation; most patients go home the same day.","restrictions":{"status":"missing","reason":"not_collected"}},{"phase":"First days after each infusion","description":"Possible mild fatigue, rash or flu-like symptoms. Promptly report cough, breathlessness, severe diarrhea or rash, jaundice or weakness.","restrictions":{"status":"missing","reason":"not_collected"}},{"phase":"Ongoing treatment","description":"Cycles every 3 or 6 weeks with monitoring for delayed immune-related side effects, which can appear months into treatment or after it ends.","restrictions":["Do not self-treat immune-related symptoms; contact the oncology team"]}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":21,"max":42,"unit":"days","qualifier":"Clinical review and blood tests before each subsequent cycle (every 3 or 6 weeks depending on regimen)."}},{"purpose":"result_review","requirement":"routine","after":{"min":42,"max":84,"unit":"days","qualifier":"First response imaging is typically about 6-12 weeks after starting treatment."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that the medical team treating you has suitable qualifications","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you checked the qualifications of the medical team treating you?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Check that you can ask the treating team questions about your treatment","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you been able to ask them questions about your treatment?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C3","text":"Check that you are satisfied with the facilities and standards where you will be treated","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Are you satisfied with the facilities and standards at the clinic or hospital where you'll be treated?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C4","text":"Check how your aftercare will be coordinated once treatment is over","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Ensure you're clear about how your aftercare will be coordinated.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C5","text":"Check whether follow-up care takes place at the same facility as the procedure","scope":"treatment_abroad","source":{"url":"https://www.cdc.gov/yellow-book/hcp/health-care-abroad/medical-tourism.html","host":"cdc.gov","quote":"Medical tourists should also know whether follow-up care is scheduled to occur at the same facility as the procedure.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":403}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"The clinic or hospital refuses to discuss the details of the treatment when asked","scope":"treatment_abroad","source":{"url":"https://www.rcseng.ac.uk/patient-care/cosmetic-surgery/having-surgery-abroad","host":"rcseng.ac.uk","quote":"Be wary of surgeons and hospitals that do not want to discuss the details of surgery with you.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Fevers or flu-like symptoms with a rash","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Contact your care team right away if you notice fevers or flu-like symptoms with a rash.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Allergic reaction to the medicine","urgency":"contact_clinic","general":false,"source":{"url":"https://www.healthline.com/health/drugs/keytruda","host":"healthline.com","quote":"Call your doctor right away if you have an allergic reaction to Keytruda.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Any change in eyesight","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Tell your care team right away if you have any change in your eyesight.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W4","text":"Shortness of breath or trouble breathing","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Dry cough, shortness of breath or trouble breathing.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W5","text":"Chest pain or fast or irregular heartbeat","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Heart muscle inflammation—unusual weakness or fatigue, shortness of breath, chest pain, fast or irregular heartbeat.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Gives your home doctor information about your treatment and future care needs","document":"discharge letter for gp","source":{"url":"https://www.nhs.uk/using-the-nhs/nhs-services/hospitals/being-discharged-from-hospital/","host":"nhs.uk","quote":"You'll also be given a letter for your GP, providing information about your treatment and future care needs.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T4","text":"Tells any doctor the patient is on immunotherapy, so side effects are managed correctly","document":"immunotherapy wallet card","source":{"url":"https://www.ons.org/toolkits/immunotherapy-patient-wallet-card-1","host":"ons.org","quote":"The ONS Immunotherapy Patient Wallet Card is intended to communicate with healthcare providers who are not involved with a patient's cancer treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Blood tests","aliases":["Blood tests","Baseline blood tests","Recent blood tests"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Liver function test","aliases":["Liver function test","liver","liver function","LFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"Kidney function test","aliases":["Kidney function test","kidney","kidney function","renal function"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"Thyroid function test","aliases":["Thyroid function test","thyroid","thyroid function","TFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Blood glucose test","aliases":["Blood glucose test","glucose","blood glucose"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Pregnancy test","aliases":["Pregnancy test"],"kind":"lab","origin":[{"field":"preparation","text":"Pregnancy test and contraception counseling where relevant"}],"what_it_checks":{"text":"Checks whether pregnancy is present because treatment can cause fetal harm","source":{"url":"https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9333c79b-d487-4538-a9f0-71b91a02b287/spl-doc?hl=mab","host":"nctr-crs.fda.gov","quote":"Based on its mechanism of action, KEYTRUDA can cause fetal harm when administered to a pregnant woman.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Hepatitis B test","aliases":["Hepatitis B test","Hepatitis B/C screening","hepatitis B screening","HBV","Hepatitis C test","hepatitis C screening","HCV"],"kind":"lab","origin":[{"field":"preparation","text":"Hepatitis B/C and HIV screening; exclude active tuberculosis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"HIV test","aliases":["HIV test","HIV screening","HIV"],"kind":"lab","origin":[{"field":"preparation","text":"Hepatitis B/C and HIV screening; exclude active tuberculosis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"PD-L1 test","aliases":["PD-L1 test","PD-L1","PD-L1 test results"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"PD-L1, MSI or dMMR test results"}],"what_it_checks":{"text":"Shows PD-L1 protein in tumor cells, guiding immunotherapy choice","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"A PD-L1 test uses a sample of cancerous tumor tissue to measure how much of a protein called programmed-death ligand 1 (PD-L1) is found on the cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"type":"case","text":"If you have certain types of cancer","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"You may need a PD-L1 test if you've been diagnosed with certain types of cancer that commonly cause high PD-L1 levels.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"test_prep":{"text":"Preparation varies with how the tumor sample is collected","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"Preparations for your test depend on how your tissue sample will be taken.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}}},{"id":"T10","name":"MSI test","aliases":["MSI test","MSI","microsatellite instability"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"PD-L1, MSI or dMMR test results"}],"what_it_checks":{"text":"Checks tumor MSI-high status, which decides if Keytruda can treat it","source":{"url":"https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9333c79b-d487-4538-a9f0-71b91a02b287/spl-doc?hl=mab","host":"nctr-crs.fda.gov","quote":"Microsatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer (CRC) for the treatment of patients with unresectable or metastatic MSI-H or dMMR colorectal cancer (CRC) as determined by an FDA-authorized test.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":2},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"visit_and_day":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":0,"max":2,"unit":"days","qualifier":"Most return to usual activities within 0-2 days, depending on fatigue, side effects and cancer type."},"complication_rate_pct":{"min":10,"max":20,"unit":"percent","qualifier":"Grade 3-5 treatment-related adverse events with monotherapy in pivotal trials; higher with chemotherapy or TKIs."},"contraindications":["Prior severe hypersensitivity to pembrolizumab or its components","Pregnancy (can harm the fetus)","Severe active autoimmune disease needing immunosuppression (relative)","Active uncontrolled infection (relative; treat first)","Prior solid organ transplant (relative; graft rejection risk)"],"days_in_clinic":{"min":0,"max":0,"unit":"nights","qualifier":"Per infusion; given as an outpatient infusion with no overnight stay."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"No procedural restriction; light activity encouraged. Strenuous exercise within about a week, limited by fatigue."},"final_result_months":{"min":3,"max":6,"unit":"months","qualifier":"Best response often seen within 3-6 months; responses may deepen later."},"fly_home_after_days":{"min":1,"max":2,"unit":"days","qualifier":"Outpatient infusion with no wound; flying is possible once no reaction occurs and you feel well."},"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":21,"max":42,"unit":"days","qualifier":"Clinical review and blood tests before each subsequent cycle (every 3 or 6 weeks depending on regimen)."}},{"purpose":"result_review","requirement":"routine","after":{"min":42,"max":84,"unit":"days","qualifier":"First response imaging is typically about 6-12 weeks after starting treatment."}}],"indications":["Advanced or metastatic melanoma; adjuvant melanoma after resection","Non-small cell lung cancer (alone or with chemotherapy)","Head and neck squamous cell carcinoma","Classical Hodgkin lymphoma (relapsed/refractory)","Urothelial carcinoma","MSI-high/dMMR solid tumors including colorectal cancer","Other approved cancers (cervical, endometrial, gastric, renal, breast)","Merkel cell carcinoma"],"main_risks":["Immune-related organ inflammation (lungs, colon, liver, thyroid, kidneys, skin)","Fatigue, rash, itching, diarrhea, nausea","Infusion-related reactions","Type 1 diabetes, adrenal or pituitary insufficiency","Myocarditis (rare)","Serious or fatal immune events needing steroids and interruption"],"pain":"Minimal; only mild discomfort from IV cannulation. Side effects such as joint or muscle pain may occur in some patients.","preparation":["Confirmed cancer and approved indication; biomarker testing if relevant","Baseline blood tests: liver, kidney, thyroid, glucose","Baseline imaging for staging","Review of autoimmune history, transplant history and current medications","Pregnancy test and contraception counseling where relevant","Discussion of side effects and when to report symptoms urgently","Hepatitis B/C and HIV screening; exclude active tuberculosis","Baseline ECOG performance status assessment","Adequate venous access for intravenous infusion"],"recovery_timeline":[{"phase":"Infusion day","description":"About 30-minute IV infusion with brief observation; most patients go home the same day.","restrictions":[]},{"phase":"First days after each infusion","description":"Possible mild fatigue, rash or flu-like symptoms. Promptly report cough, breathlessness, severe diarrhea or rash, jaundice or weakness.","restrictions":[]},{"phase":"Ongoing treatment","description":"Cycles every 3 or 6 weeks with monitoring for delayed immune-related side effects, which can appear months into treatment or after it ends.","restrictions":["Do not self-treat immune-related symptoms; contact the oncology team"]}],"rehabilitation_days":{"min":0,"max":2,"unit":"days","qualifier":"Outpatient infusion with no surgical recovery; usual activities resume within 0-2 days, depending on fatigue and side effects."},"result_longevity":"In responders, benefit is often durable, lasting years and sometimes continuing after the course (up to about 2 years) ends. Duration depends on cancer type, stage and biomarkers.","revision_rate_pct":null,"scars":"No scarring is expected; at most there is a tiny, temporary mark at the IV cannulation site.","sessions_or_stages":{"sessions":{"min":1,"max":35,"unit":"visits","qualifier":"Infusions every 3 or 6 weeks for up to about 2 years (35 three-weekly cycles) or until progression."},"stages":[{"code":"infusion_cycles","label":"Repeated intravenous pembrolizumab infusions every 3 or 6 weeks","after":{"min":0,"max":730,"unit":"days","qualifier":"Spans the whole course from the first infusion."}}],"qualifier":"Number of cycles depends on cancer type, regimen, response and tolerance."},"success":{"metric":"Overall survival at 5 years (advanced NSCLC, PD-L1 ≥50%)","value":31.9,"unit":"percent","horizon":"5 years","population":"Adults with untreated advanced NSCLC, PD-L1 ≥50%, on pembrolizumab monotherapy","evidence_status":"limited"},"techniques":[{"name":"Pembrolizumab monotherapy","suits_whom":"Patients with suitable biomarkers (e.g., high PD-L1, MSI-high) or melanoma","recovery":"Outpatient infusion; no downtime in most patients."},{"name":"Pembrolizumab combined with chemotherapy","suits_whom":"Patients such as those with non-small cell lung cancer or other tumors where the combination is approved","recovery":"Added chemotherapy side effects can increase fatigue and recovery time after each cycle."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":0.5,"max":1,"unit":"hours","qualifier":"Dose (200 mg every 3 weeks or 400 mg every 6 weeks) infused over 30 minutes, plus brief observation."},"initial_assessment_documents":["Pathology report with histology","PD-L1, MSI or dMMR test results","Staging CT or PET-CT reports","Prior treatment and surgery summary","Recent blood tests with liver and thyroid function","Oncologist letter on autoimmune disease or ECOG status"],"travel_trips":{"min":2,"max":35,"one_trip_possible":false,"qualifier":"Each 3- or 6-weekly infusion needs a visit; stay 1-3 days per trip. Fewer if a local oncologist continues."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that the medical team treating you has suitable qualifications","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you checked the qualifications of the medical team treating you?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Check that you can ask the treating team questions about your treatment","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you been able to ask them questions about your treatment?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C3","text":"Check that you are satisfied with the facilities and standards where you will be treated","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Are you satisfied with the facilities and standards at the clinic or hospital where you'll be treated?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C4","text":"Check how your aftercare will be coordinated once treatment is over","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Ensure you're clear about how your aftercare will be coordinated.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C5","text":"Check whether follow-up care takes place at the same facility as the procedure","scope":"treatment_abroad","source":{"url":"https://www.cdc.gov/yellow-book/hcp/health-care-abroad/medical-tourism.html","host":"cdc.gov","quote":"Medical tourists should also know whether follow-up care is scheduled to occur at the same facility as the procedure.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":403}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"The clinic or hospital refuses to discuss the details of the treatment when asked","scope":"treatment_abroad","source":{"url":"https://www.rcseng.ac.uk/patient-care/cosmetic-surgery/having-surgery-abroad","host":"rcseng.ac.uk","quote":"Be wary of surgeons and hospitals that do not want to discuss the details of surgery with you.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Fevers or flu-like symptoms with a rash","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Contact your care team right away if you notice fevers or flu-like symptoms with a rash.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Allergic reaction to the medicine","urgency":"contact_clinic","general":false,"source":{"url":"https://www.healthline.com/health/drugs/keytruda","host":"healthline.com","quote":"Call your doctor right away if you have an allergic reaction to Keytruda.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Any change in eyesight","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Tell your care team right away if you have any change in your eyesight.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W4","text":"Shortness of breath or trouble breathing","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Dry cough, shortness of breath or trouble breathing.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W5","text":"Chest pain or fast or irregular heartbeat","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Heart muscle inflammation—unusual weakness or fatigue, shortness of breath, chest pain, fast or irregular heartbeat.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Gives your home doctor information about your treatment and future care needs","document":"discharge letter for gp","source":{"url":"https://www.nhs.uk/using-the-nhs/nhs-services/hospitals/being-discharged-from-hospital/","host":"nhs.uk","quote":"You'll also be given a letter for your GP, providing information about your treatment and future care needs.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T4","text":"Tells any doctor the patient is on immunotherapy, so side effects are managed correctly","document":"immunotherapy wallet card","source":{"url":"https://www.ons.org/toolkits/immunotherapy-patient-wallet-card-1","host":"ons.org","quote":"The ONS Immunotherapy Patient Wallet Card is intended to communicate with healthcare providers who are not involved with a patient's cancer treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your advanced lung cancer has spread to other body parts","name":"Targeted medicines for lung cancer","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment","host":"nhs.uk","quote":"Targeted medicines or immunotherapy are sometimes used to treat advanced lung cancer that has spread to other parts of the body.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":null}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"technique_details":{"status":"ok","items":[{"id":"pembrolizumab-monotherapy","name":"Pembrolizumab monotherapy","how_it_works":{"text":"The antibody blocks immune-inhibiting signals, allowing an anti-tumor immune response","source":{"url":"https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9333c79b-d487-4538-a9f0-71b91a02b287/spl-doc?hl=pembro","host":"nctr-crs.fda.gov","quote":"Pembrolizumab is a monoclonal antibody that binds to the PD-1 receptor and blocks its interaction with PD-L1 and PD-L2, releasing PD-1 pathway-mediated inhibition of the immune response, including the anti-tumor immune response.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"pembrolizumab-combined","name":"Pembrolizumab combined with chemotherapy","how_it_works":{"text":"The antibody is administered with another cancer treatment to treat cancer","source":{"url":"https://api.fda.gov/drug/label.json?search=openfda.application_number:%22BLA761467%22&limit=1","host":"api.fda.gov","quote":"The most common adverse reactions (≥20%) in patients receiving intravenous pembrolizumab and axitinib were diarrhea, fatigue/asthenia, hypertension, hypothyroidism, decreased appetite, hepatotoxicity, palmar-plantar erythrodysesthesia, nausea, stomatitis/mucosal inflammation, dysphonia, rash, cough, and constipation.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Blood tests","aliases":["Blood tests","Baseline blood tests","Recent blood tests"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Liver function test","aliases":["Liver function test","liver","liver function","LFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"Kidney function test","aliases":["Kidney function test","kidney","kidney function","renal function"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"Thyroid function test","aliases":["Thyroid function test","thyroid","thyroid function","TFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Blood glucose test","aliases":["Blood glucose test","glucose","blood glucose"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Pregnancy test","aliases":["Pregnancy test"],"kind":"lab","origin":[{"field":"preparation","text":"Pregnancy test and contraception counseling where relevant"}],"what_it_checks":{"text":"Checks whether pregnancy is present because treatment can cause fetal harm","source":{"url":"https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9333c79b-d487-4538-a9f0-71b91a02b287/spl-doc?hl=mab","host":"nctr-crs.fda.gov","quote":"Based on its mechanism of action, KEYTRUDA can cause fetal harm when administered to a pregnant woman.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Hepatitis B test","aliases":["Hepatitis B test","Hepatitis B/C screening","hepatitis B screening","HBV","Hepatitis C test","hepatitis C screening","HCV"],"kind":"lab","origin":[{"field":"preparation","text":"Hepatitis B/C and HIV screening; exclude active tuberculosis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"HIV test","aliases":["HIV test","HIV screening","HIV"],"kind":"lab","origin":[{"field":"preparation","text":"Hepatitis B/C and HIV screening; exclude active tuberculosis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"PD-L1 test","aliases":["PD-L1 test","PD-L1","PD-L1 test results"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"PD-L1, MSI or dMMR test results"}],"what_it_checks":{"text":"Shows PD-L1 protein in tumor cells, guiding immunotherapy choice","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"A PD-L1 test uses a sample of cancerous tumor tissue to measure how much of a protein called programmed-death ligand 1 (PD-L1) is found on the cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"type":"case","text":"If you have certain types of cancer","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"You may need a PD-L1 test if you've been diagnosed with certain types of cancer that commonly cause high PD-L1 levels.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"test_prep":{"text":"Preparation varies with how the tumor sample is collected","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"Preparations for your test depend on how your tissue sample will be taken.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}}},{"id":"T10","name":"MSI test","aliases":["MSI test","MSI","microsatellite instability"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"PD-L1, MSI or dMMR test results"}],"what_it_checks":{"text":"Checks tumor MSI-high status, which decides if Keytruda can treat it","source":{"url":"https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9333c79b-d487-4538-a9f0-71b91a02b287/spl-doc?hl=mab","host":"nctr-crs.fda.gov","quote":"Microsatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer (CRC) for the treatment of patients with unresectable or metastatic MSI-H or dMMR colorectal cancer (CRC) as determined by an FDA-authorized test.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":2},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"visit_and_day":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"}}},"techniques":[{"id":"pembrolizumab-monotherapy","name":"Pembrolizumab monotherapy","how_it_works":{"id":"H1","text":"The antibody blocks immune-inhibiting signals, allowing an anti-tumor immune response","source":{"url":"https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9333c79b-d487-4538-a9f0-71b91a02b287/spl-doc?hl=pembro","host":"nctr-crs.fda.gov","quote":"Pembrolizumab is a monoclonal antibody that binds to the PD-1 receptor and blocks its interaction with PD-L1 and PD-L2, releasing PD-1 pathway-mediated inhibition of the immune response, including the anti-tumor immune response.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Patients with suitable biomarkers (e.g., high PD-L1, MSI-high) or melanoma","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Outpatient infusion; no downtime in most patients."},{"id":"pembrolizumab-combined","name":"Pembrolizumab combined with chemotherapy","how_it_works":{"id":"H1","text":"The antibody is administered with another cancer treatment to treat cancer","source":{"url":"https://api.fda.gov/drug/label.json?search=openfda.application_number:%22BLA761467%22&limit=1","host":"api.fda.gov","quote":"The most common adverse reactions (≥20%) in patients receiving intravenous pembrolizumab and axitinib were diarrhea, fatigue/asthenia, hypertension, hypothyroidism, decreased appetite, hepatotoxicity, palmar-plantar erythrodysesthesia, nausea, stomatitis/mucosal inflammation, dysphonia, rash, cough, and constipation.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Patients such as those with non-small cell lung cancer or other tumors where the combination is approved","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Added chemotherapy side effects can increase fatigue and recovery time after each cycle."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your advanced lung cancer has spread to other body parts","name":"Targeted medicines for lung cancer","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment","host":"nhs.uk","quote":"Targeted medicines or immunotherapy are sometimes used to treat advanced lung cancer that has spread to other parts of the body.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":null}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-12","next_check_at":"2027-02-10"},"travel":{"status":"ok","items":[{"id":"V1","item":"visa","audience":"uk","volatile":true,"text":"Under Thailand's visa exemption scheme, you can stay up to 30 days for tourism only","source":{"url":"https://www.gov.uk/foreign-travel-advice/thailand/entry-requirements","host":"gov.uk","quote":"From 15 September 2026, if you enter Thailand under the visa exemption scheme, you can stay for up to 30 days for tourism only.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"visa","audience":"us","volatile":true,"text":"U.S. citizen tourists staying fewer than 60 days in Thailand need no visa, but must complete pre-arrival online registration","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Thailand.html","host":"travel.state.gov","quote":"U.S. citizen tourists entering Thailand for fewer than 60 days do not require a visa but pre-arrival online registration is required.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"passport_validity","audience":"uk","volatile":true,"text":"Your passport must expire at least 6 months after the date you arrive in Thailand and have at least 1 blank page","source":{"url":"https://www.gov.uk/foreign-travel-advice/thailand/entry-requirements","host":"gov.uk","quote":"To enter Thailand, your passport must have an ‘expiry date’ at least 6 months after the date you arrive and have at least 1 blank page.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V4","item":"passport_validity","audience":"us","volatile":true,"text":"U.S. travelers are strongly advised to hold a passport valid at least six months beyond the arrival date in Thailand to avoid possible denied entry","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Thailand.html","host":"travel.state.gov","quote":"We strongly recommend that your passport be valid for at least six months beyond the date of your arrival in Thailand to avoid possible denied entry.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V5","item":"medicines","audience":"all","volatile":false,"text":"Up to a 30-day supply of medicine for personal use may be brought into Thailand with you","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Thailand.html","host":"travel.state.gov","quote":"Medicine for personal use: Up to a 30-day supply may be brought into the country with you.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V6","item":"emergency_number","audience":"all","volatile":false,"text":"Dial 1669 for Emergency Medical Services (EMS) in Thailand","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Thailand.html","host":"travel.state.gov","quote":"For emergency services in Thailand, dial 1669 for Emergency Medical Services (EMS).","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["azerbaijan","china","dominican-republic","egypt","germany","india","israel","italy","japan","malaysia","mexico","morocco","republic-of-korea","spain","switzerland","turkey","ukraine","united-states"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.6,"count":131,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Immunotherapy with Keytruda (pembrolizumab) in Thailand has an estimated price from _op_491_price_from_ to _op_491_price_to_; this is not a clinic quote. The final amount depends on dosage, treatment schedule, hospital tier, and location. Bangkok private hospitals may cost more than specialized public or university-affiliated centers. In the US, this procedure costs _price_compare_US_average_ on average. Typical quotes may include the Keytruda vial, oncologist consultation, infusion administration, and basic pre-infusion laboratory tests.</p>\n<ul>\n<li><strong>Dosage.</strong> Fixed-dose or weight-based treatment affects medication costs.</li>\n<li><strong>Treatment schedule.</strong> The interval between infusions can affect the total treatment budget.</li>\n<li><strong>Hospital tier.</strong> Bangkok private hospitals may cost 30%–40% more than specialized public or university-affiliated centers.</li>\n<li><strong>Pre-treatment testing.</strong> PD-L1 testing and other biomarker panels may be billed separately.</li>\n</ul>\n<p><strong>Bookimed Expert Insight.</strong> A facility-specific estimate should not be treated as the countrywide estimate. Bumrungrad International Hospital in Bangkok lists approximately $3,200–$7,700 for this treatment. Its profile shows a 4.6 rating from 131 reviews and more than 1,000,000 patients annually. Patients can use the listed figure as a facility reference, then confirm the dose and included services directly.</p>","faq":[{"q":"Is Keytruda immunotherapy available and approved in Thailand?","a":"<p>Keytruda (pembrolizumab) is fully approved by the Thai Food and Drug Administration. Major medical hubs in Bangkok, Phuket, and Pattaya provide this immunotherapy. Leading JCI-accredited facilities like Bumrungrad International Hospital offer PD-1 inhibitor treatments for advanced lung cancer, melanoma, and various solid tumors.</p> <ul> <li><strong>Approval status:</strong> Thai FDA approved pembrolizumab for multiple cancer indications since 2017.</li> <li><strong>Clinical availability:</strong> Available at top-tier centers including Bumrungrad International and Bangkok Hospital.</li> <li><strong>Diagnostic requirement:</strong> Clinics perform PD-L1 testing to determine patient eligibility before administration.</li> <li><strong>Cost profile:</strong> Treatment ranges from _op_491_price_from_ to _op_491_price_to_ per protocol.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Thailand ranks 4th globally for medical tourism requests on our platform. High-volume centers like Bumrungrad serve over 1 million patients annually. Their experience with international protocols ensures consistent drug cold-chain management. This reliability is crucial for biological drugs like Keytruda to maintain efficacy.</p> <p><strong>Patient Consensus:</strong> Patients report successful outcomes for lung and head-and-neck cancers matching Western standards. They recommend bringing full medical records to bypass diagnostic delays at major Bangkok clinics.</p>"},{"q":"Who is an ideal candidate for Keytruda treatment in Thailand?","a":"<p>Ideal candidates for Keytruda in Thailand are patients with advanced or metastatic cancers expressing PD-L1 biomarkers. This includes non-small cell lung cancer, melanoma, and head and neck squamous cell carcinoma. Patients with microsatellite instability-high or mismatch repair deficient solid tumors also qualify for this immunotherapy.</p> <ul> <li><strong>Biomarker profile:</strong> Focus on tumors showing PD-L1 expression or MSI-H/dMMR genetic markers.</li> <li><strong>Treatment history:</strong> Patients who have progressed after receiving standard platinum-based chemotherapy protocols.</li> <li><strong>Health status:</strong> Candidates must lack active autoimmune disorders or a history of thyroiditis.</li> <li><strong>Facility access:</strong> Ideal for travelers seeking JCI-accredited care at centers like Bumrungrad International Hospital.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many clinics offer immunotherapy, Bumrungrad International Hospital serves over 500,000 international patients annually. This massive volume ensures oncology teams are highly experienced with complex pembrolizumab protocols. Patients often save up to _price_percent_discount_% compared to US costs for the same medication.</p> <p><strong>Patient Consensus:</strong> Success depends on completing the full series of 6 to 12 infusions. Most recommend finishing all PD-L1 and MSI testing before traveling to ensure treatment can begin immediately.</p>"},{"q":"What are the main safety risks and side-effects I should watch for?","a":"<p>Immunotherapy with Keytruda in Thailand requires monitoring for immune-related adverse events where the immune system attacks healthy organs. Patients must watch for pneumonitis, colitis, and endocrine dysfunctions. High-tech facilities like Bumrungrad International Hospital utilize advanced diagnostics to manage these risks during treatment.</p> <ul> <li><strong>Respiratory warning:</strong> Watch for new cough or shortness of breath signaling pneumonitis.</li> <li><strong>Gastrointestinal health:</strong> Report severe diarrhea or bloody stools immediately to prevent bowel perforation.</li> <li><strong>Endocrine monitoring:</strong> Fatigue or heart palpitations often indicate thyroid dysfunction or adrenal insufficiency.</li> <li><strong>Dermatological checks:</strong> Contact specialists if widespread rashes or painful skin blistering occur.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many focus on immediate reactions, our data from Bumrungrad International Hospital shows that long-term safety is tied to their multidisciplinary approach. With 70 specialized departments, they can transition patients seamlessly from oncology to endocrinology if Keytruda triggers internal issues like type 1 diabetes. This internal infrastructure is why 50% of their 1,000,000 annual patients travel from 190 countries for complex immunotherapy.</p> <p><strong>Patient Consensus:</strong> Patients emphasize tracking daily energy levels and skin changes. Many describe a unique, bone-deep exhaustion and stress the importance of having baseline lung and thyroid tests before the first infusion.</p>"},{"q":"How is Keytruda administered, and what does a full cycle schedule look like?","a":"<p>Keytruda is administered as an intravenous (IV) infusion into a vein over 30 to 60 minutes. Adults typically receive 200 mg every 3 weeks or 400 mg every 6 weeks. This immunotherapy continues for up to 24 months depending on cancer type and response.</p> <ul> <li><strong>Administration method:</strong> Healthcare professionals provide infusions in outpatient settings at hospitals like Bumrungrad International Hospital.</li> <li><strong>Cycle frequency:</strong> Patients follow a strict schedule of either 3-week or 6-week treatment intervals.</li> <li><strong>Pediatric dosing:</strong> Children receive 2 mg/kg per dose, capped at a maximum of 200 mg.</li> <li><strong>Treatment duration:</strong> Most regimens last 12 to 24 months to ensure a sustained immune response.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Thailand oncology centers like Bumrungrad International Hospital often provide international patients with coordinated scheduling. They sync diagnostic scans with infusion dates to minimize travel days. This efficiency is why the clinic has served over 360 patients through our platform.</p> <p><strong>Patient Consensus:</strong> Patients often mention that the 30-minute infusion is relatively quick and manageable. Most report a peak in fatigue around day 3 but find it stabilizes quickly afterward.</p>"},{"q":"Which hospitals have the most experienced immunotherapy teams and technology for Keytruda in Thailand?","a":"<p>Thailand headquarters world-class immunotherapy at JCI-accredited facilities like Bumrungrad International and Wattanosoth Cancer Hospital. These centers utilize advanced precision medicine, PET-CT monitoring, and MD Anderson-aligned protocols. Expert onco-hematologists specialize in Keytruda applications for lung, melanoma, and gastrointestinal cancers with international clinical standards.</p> <ul> <li><strong>Bumrungrad International:</strong> Features Horizon Regional Cancer Center treating over 1 million patients annually with JCI-accredited expertise.</li> <li><strong>Technology integration:</strong> Facilities use TrueBeam STx radiation and PET-CT scanners for precise treatment monitoring.</li> <li><strong>Specialized expertise:</strong> Teams include overseas-trained oncologists like Dr. Surasit Saleh Issarachai with extensive Keytruda experience.</li> <li><strong>Academic research:</strong> Siriraj Piyamaharajkarun Hospital offers Southeast Asia’s first MR-LINAC for high-definition guided cancer therapy.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many private hospitals offer Keytruda, top-tier centers like Bumrungrad treat patients from 190+ countries. This high volume across diverse ethnicities provides their teams with unique data on dosage adjustments. Choosing a high-volume center often ensures more reliable access to genuine MSD-manufactured Pembrolizumab stocks.</p> <p><strong>Patient Consensus:</strong> Patients emphasize completing PD-L1 biomarker testing before arrival to speed up the first infusion. Most report that English-speaking teams in Bangkok manage complex immunotherapy side effects with western-level proficiency.</p>"},{"q":"How long will I need to stay in Thailand per infusion, and is continuous residency required?","a":"<p>Immunotherapy sessions with Keytruda in Thailand typically require 3 to 7 days per visit. This timeframe allows for pre-treatment blood labs, the 30 to 60-minute infusion, and short-term monitoring. Patients do not need continuous residency and safely return home between 3-week treatment cycles.</p> <ul> <li><strong>Infusion duration:</strong> The Keytruda administration usually takes 30 to 60 minutes per session.</li> <li><strong>Clinical stay:</strong> Expect 3 to 7 days in-country for labs, treatment, and medical clearance.</li> <li><strong>Residency rules:</strong> Continuous stay is not required; travel between cycles is clinically acceptable.</li> <li><strong>Visa strategy:</strong> Standard 60-day tourist visas cover initial cycles without complex medical permit applications.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While single-session visits are possible, many international patients at Bumrungrad International Hospital stay for two full cycles. Staying 21 days allows doctors to monitor the first immune response and adjust the second dose. This approach often reduces long-haul flight fatigue which can impact overall recovery and immune health.</p> <p><strong>Patient Consensus:</strong> Most patients prioritize a 7-day buffer for the first infusion to manage potential side effects. The consensus highlights that arranging remote follow-up with a local oncologist makes the commute between Thailand and home much safer.</p>"}],"h2":[{"text":"Qual è il prezzo di Immunoterapia con Keytruda (Pembrolizumab) in Thailandia? Scoprilo ora","kind":"content"},{"text":"I tuoi benefici e le tue garanzie con Bookimed","kind":"content"},{"text":"Il tuo coordinatore medico Bookimed personale","kind":"content"},{"text":"Scopri le migliori cliniche di Immunoterapia con Keytruda (Pembrolizumab) in Thailandia: 1 opzioni verificate e Prezzi","kind":"content"},{"text":"Panoramica di Immunoterapia con Keytruda (Pembrolizumab) in Thailandia","kind":"content"},{"text":"Ottieni una valutazione medica per Immunoterapia con Keytruda (Pembrolizumab) in Thailandia: scegli il tuo specialista tra i migliori nel settore","kind":"content"},{"text":"Storie in video dei pazienti Bookimed","kind":"content"},{"text":"Recensioni","kind":"content"},{"text":"Condividi contenuto","kind":"content"},{"text":"Dati chiave su Immunoterapia con Keytruda (Pembrolizumab)","kind":"content"},{"text":"Domande frequenti su Immunoterapia con Keytruda (Pembrolizumab) in Thailandia","kind":"content"},{"text":"Richiedi una consulenza gratuita","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}